Sector footprint
$133.8K in exports
Reported chemicals exports in 2024 across 30 qualifying HS6 products.
Sector export playbook ยท HS 28-38
Tonga Chemicals exports
where capability meets demand
Explore Tonga's HS 28-38 product portfolio, buyer markets, growth signals, and diversification opportunities. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
Sector exports$133.8K2024 reported value
Products30Qualifying HS6 products
Buyer markets15Markets represented
Average CAGR-1.2%Product-level growth signal
Global sector size$206.7BReported buyer imports
Chemicals capability
How strong is Tonga in this sector?
Compare exporter scale with product breadth, buyer demand, growth, and destination reach. A large sector does not remove the need for product, compliance, pricing, and buyer validation.
Global demand
$206.7B buyer imports
The sector's reported buyer import base provides context for product and market prioritization.
How to use the guide
Find the next credible move
Start with products that combine demand and exporter capability, then validate standards, route economics, buyers, and competition.
Product portfolio
Which products anchor the sector?
Each HS6 product is ranked by calculated opportunity and shown with reported market size, exporter exports, growth, and destination reach.
| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
|---|---|---|---|---|---|---|
| HS 300215Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $67.6B | $0.2 | $25.9B | -49.6% | 1 | +0.0% |
| HS 300214Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $15.4B | $0.2 | $23.5B | -49.6% | 1 | +0.0% |
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $82.3B | $110.3 | $20.1B | +23.3% | 5 | +0.0% |
| HS 300212Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $8.5B | $0.2 | $4.3B | -49.6% | 1 | +0.0% |
| HS 300439Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $9.4B | $42.1 | $3.6B | -5.8% | 2 | +0.0% |
| HS 330300Perfumes and toilet waters | $6.8B | $11.1K | $3.6B | -5.0% | 5 | +0.0% |
| HS 300420Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $3.8 | $2.0B | -0.8% | 1 | +0.0% |
| HS 330499Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $2.5B | $234.1 | $1.5B | -18.8% | 3 | +0.0% |
| HS 340220Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $1.2B | $296.4 | $1.4B | -36.6% | 1 | +0.0% |
| HS 300390Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $1.8B | $43.6 | $1.2B | -3.6% | 1 | +0.0% |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $2.7B | $11.3 | $1.0B | +33.4% | 2 | +0.0% |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $1.1B | $699.4 | $790.7M | +22.5% | 1 | +0.0% |
| HS 340290Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), including auxiliary washing preparations, not for retail sale | $240.6M | $55.4 | $228.3M | +131.5% | 1 | +0.0% |
| HS 300190Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001 | $459.6M | $561.7 | $222.6M | -4.0% | 3 | +0.0% |
| HS 330190Oils, essential: concentrates in fats, fixed oils, waxes and the like, terpenic by-products, aqueous distillates and solutions, extracted oleoresins, n.e.c. in heading no. 3301 | $242.1M | $54.8 | $181.0M | +8.0% | 2 | +0.0% |
| HS 300219Blood, human or animal, antisera, other blood fractions and immunological products: n.e.c. in heading 3002.1 | $398.9M | $0.2 | $140.6M | -49.6% | 1 | +0.0% |
| HS 300213Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale | $322.9M | $0.2 | $129.3M | -49.6% | 1 | +0.0% |
| HS 300450Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | $349.4M | $15.0K | $123.9M | +26.2% | 3 | +0.1% |
| HS 320810Paints and varnishes: based on polyesters, dispersed or dissolved in a non-aqueous medium | $157.7M | $19.9K | $96.7M | +14.5% | 1 | +0.0% |
| HS 330210Odoriferous substances and mixtures: of a kind used in the food or drink industries | $185.3M | $199.1 | $95.8M | -10.6% | 1 | +0.0% |
| HS 320820Paints and varnishes: based on acrylic or vinyl polymers, dispersed or dissolved in a non-aqueous medium | $280.5M | $3.0K | $86.2M | -16.5% | 1 | +0.0% |
| HS 330129Oils, essential: n.e.s. in heading no. 3301 (terpeneless or not), including concretes and absolutes | $380.0M | $71.6 | $78.7M | -76.5% | 1 | +0.0% |
| HS 321590Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $203.9M | $957.0 | $69.5M | -0.5% | 2 | +0.0% |
| HS 330590Hair preparations: n.e.s. in heading no. 3305 | $222.0M | $0.0 | $67.1M | -100.0% | 1 | +0.0% |
| HS 290949Ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives: n.e.s. in item no. 2909.4 | $68.9M | $46.5K | $38.8M | +67.6% | 1 | +0.1% |
| HS 320890Paints and varnishes: based on polymers n.e.s. in heading no. 3208, dispersed or dissolved in a non-aqueous medium | $50.8M | $17.6K | $27.0M | +19.5% | 2 | +0.0% |
| HS 320910Paints and varnishes: based on acrylic or vinyl polymers, dispersed or dissolved in an aqueous medium | $19.7M | $1.2K | $18.9M | -27.8% | 1 | +0.0% |
| HS 300650Pharmaceutical goods: first aid boxes and kits | $14.8M | $0.3 | $17.6M | -7.8% | 1 | +0.0% |
| HS 330510Hair preparations: shampoos | $30.0M | $0.0 | $14.1M | -96.2% | 1 | +0.0% |
| HS 321000Paints and varnishes: (including enamels, lacquers and distempers), prepared water pigments of a kind used for finishing leather | $12.9M | $16.1K | $11.8M | +116.8% | 1 | +0.4% |
Best markets
Where does sector demand concentrate?
Markets are ranked by calculated opportunity across the qualifying products in this sector view.
USA
USA, Puerto Rico and US Virgin Islands
17 products represented in the sector.
$84.2B$193.5B reported buyer importsCAN
Canada
4 products represented in the sector.
$3.4B$3.9B reported buyer importsAUS
Australia
7 products represented in the sector.
$1.4B$6.2B reported buyer importsNZL
New Zealand
8 products represented in the sector.
$513.5M$1.2B reported buyer importsSAU
Saudi Arabia
1 products represented in the sector.
$384.8M$593.6M reported buyer importsBEL
Belgium
1 products represented in the sector.
$175.6M$523.2M reported buyer importsAUT
Austria
1 products represented in the sector.
$95.8M$185.3M reported buyer importsWXD
World excl. Intra-EU
3 products represented in the sector.
$62.4M$228.4M reported buyer importsCHN
China
1 products represented in the sector.
$60.4M$183.5M reported buyer importsESP
Spain
1 products represented in the sector.
$38.8M$68.9M reported buyer importsKOR
Republic of Korea
1 products represented in the sector.
$29.7M$64.5M reported buyer importsGBR
United Kingdom
1 products represented in the sector.
$28.1M$43.9M reported buyer importsGrowth stars
Which products show the strongest growth?
Average product-level CAGR is a screening signal. Confirm the latest trend, base effects, buyer quality, and commercial feasibility before acting.
| Product | Average CAGR | Opportunity | Markets |
|---|---|---|---|
| HS 340290Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), including auxiliary washing preparations, not for retail sale | +131.5% | $228.3M | 1 |
| HS 321000Paints and varnishes: (including enamels, lacquers and distempers), prepared water pigments of a kind used for finishing leather | +116.8% | $11.8M | 1 |
| HS 290949Ether-alcohols and their halogenated, sulphonated, nitrated or nitrosated derivatives: n.e.s. in item no. 2909.4 | +67.6% | $38.8M | 1 |
| HS 300290Toxins, cultures of micro-organisms (excluding yeasts) and similar products | +33.4% | $1.0B | 2 |
| HS 300450Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | +26.2% | $123.9M | 3 |
| HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | +23.3% | $20.1B | 5 |
| HS 382200Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | +22.5% | $790.7M | 1 |
| HS 320890Paints and varnishes: based on polymers n.e.s. in heading no. 3208, dispersed or dissolved in a non-aqueous medium | +19.5% | $27.0M | 2 |
| HS 320810Paints and varnishes: based on polyesters, dispersed or dissolved in a non-aqueous medium | +14.5% | $96.7M | 1 |
| HS 330190Oils, essential: concentrates in fats, fixed oils, waxes and the like, terpenic by-products, aqueous distillates and solutions, extracted oleoresins, n.e.c. in heading no. 3301 | +8.0% | $181.0M | 2 |
Diversification opportunities
Which products reach the widest buyer base?
Destination count is a simple breadth indicator. It does not measure destination concentration or guarantee resilience.
HS 300490
Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
5 markets$20.1B calculated opportunityHS 330300
Perfumes and toilet waters
5 markets$3.6B calculated opportunityHS 330499
Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations)
3 markets$1.5B calculated opportunityHS 300190
Glands and other organs: heparin and its salts: other human or animal substances prepared for therapeutic or prophylactic uses, n.e.c. in heading 3001
3 markets$222.6M calculated opportunityHS 300450
Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale
3 markets$123.9M calculated opportunityHS 300439
Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale
2 markets$3.6B calculated opportunityHS 300290
Toxins, cultures of micro-organisms (excluding yeasts) and similar products
2 markets$1.0B calculated opportunityHS 330190
Oils, essential: concentrates in fats, fixed oils, waxes and the like, terpenic by-products, aqueous distillates and solutions, extracted oleoresins, n.e.c. in heading no. 3301
2 markets$181.0M calculated opportunityFrequently asked questions
Using the Chemicals export playbook
Practical guidance for interpreting sector scale, growth, product breadth, and buyer markets.
How strong is Tonga in this sector?
Compare sector exports, product breadth, buyer markets, growth, and global demand. These signals identify research priorities rather than guarantee market access.
What are growth stars?
Products with higher average reported growth in the screened rows. Validate the time period, base effects, buyer demand, and current exporter position.
What does diversification mean here?
Products reaching more buyer markets in the screened data. Destination breadth is useful context but does not replace concentration, route, or buyer analysis.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.